Reference
Matsumoto Y, et al. Anti-adalimumab and anti-infliximab antibodies developed in psoriasis vulgaris patients reduced the efficacy of biologics: Report of two cases. Journal of Dermatology 40: 389-392, No. 5, May 2013 - Japan
Rights and permissions
About this article
Cite this article
Adalimumab/infliximab. Reactions Weekly 1552, 16 (2015). https://doi.org/10.1007/s40278-015-0812-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-0812-6